Johnson & Johnson (JNJ) Holder Northern Trust Corp Has Cut Its Stake as Share Value Declined

April 25, 2018 - By Stephen Andrade

Johnson & Johnson (NYSE:JNJ) LogoInvestors sentiment increased to 0.87 in Q4 2017. Its up 0.04, from 0.83 in 2017Q3. It improved, as 35 investors sold JNJ shares while 884 reduced holdings. 143 funds opened positions while 654 raised stakes. 1.72 billion shares or 0.40% more from 1.71 billion shares in 2017Q3 were reported. 698,363 were accumulated by Welch & Forbes Ltd. Twin Tree Management L P, Texas-based fund reported 1,614 shares. F&V Mngmt Limited Liability Com invested in 0.31% or 4,337 shares. Georgia-based First City Capital Mngmt has invested 1.37% in Johnson & Johnson (NYSE:JNJ). Bainco Intll Invsts holds 3.64% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 226,776 shares. Fifth Third National Bank has invested 1.33% in Johnson & Johnson (NYSE:JNJ). Schafer Cullen Incorporated invested in 1.18M shares. Sterling Investment Management holds 2,410 shares or 0.36% of its portfolio. 21,604 were reported by Brookstone. Riverhead Mgmt Limited Liability Com, Delaware-based fund reported 163,574 shares. 24,481 were reported by Bath Savings Trust. Janney Ltd invested 1.8% of its portfolio in Johnson & Johnson (NYSE:JNJ). Credit Agricole S A reported 53,873 shares stake. The New York-based Northstar has invested 2.73% in Johnson & Johnson (NYSE:JNJ). Endurance Wealth accumulated 0.86% or 38,233 shares.

Since February 15, 2018, it had 0 insider purchases, and 1 insider sale for $20.17 million activity.

Northern Trust Corp decreased its stake in Johnson & Johnson (JNJ) by 1.47% based on its latest 2017Q4 regulatory filing with the SEC. Northern Trust Corp sold 524,022 shares as the company’s stock declined 9.21% with the market. The institutional investor held 35.12M shares of the major pharmaceuticals company at the end of 2017Q4, valued at $4.91B, down from 35.64M at the end of the previous reported quarter. Northern Trust Corp who had been investing in Johnson & Johnson for a number of months, seems to be less bullish one the $338.52 billion market cap company. The stock decreased 0.50% or $0.64 during the last trading session, reaching $126.19. About 6.58 million shares traded. Johnson & Johnson (NYSE:JNJ) has risen 1.12% since April 25, 2017 and is uptrending. It has underperformed by 10.43% the S&P500.

Northern Trust Corp, which manages about $394.86 billion US Long portfolio, upped its stake in Ishares Tr (IBB) by 60,354 shares to 99,898 shares, valued at $10.67 million in 2017Q4, according to the filing. It also increased its holding in Taiwan Semiconductor Mfg Ltd (NYSE:TSM) by 78,907 shares in the quarter, for a total of 7.82M shares, and has risen its stake in Rexford Indl Rlty Inc (NYSE:REXR).

Johnson & Johnson (NYSE:JNJ) Ratings Coverage

Among 10 analysts covering Johnson & Johnson (NYSE:JNJ), 5 have Buy rating, 1 Sell and 4 Hold. Therefore 50% are positive. Johnson & Johnson had 17 analyst reports since January 2, 2018 according to SRatingsIntel. The stock of Johnson & Johnson (NYSE:JNJ) has “Outperform” rating given on Friday, April 20 by Credit Suisse. The rating was maintained by Citigroup with “Neutral” on Tuesday, February 27. The rating was maintained by Wells Fargo with “Buy” on Friday, January 12. Credit Suisse upgraded the stock to “Buy” rating in Thursday, April 12 report. Jefferies maintained Johnson & Johnson (NYSE:JNJ) rating on Tuesday, January 16. Jefferies has “Buy” rating and $170.0 target. The firm has “Buy” rating by Wells Fargo given on Wednesday, April 18. The firm has “Hold” rating by Stifel Nicolaus given on Wednesday, January 24. The rating was maintained by Jefferies on Friday, March 23 with “Buy”. The stock has “Buy” rating by Deutsche Bank on Wednesday, April 18. The firm has “Sell” rating by BTIG Research given on Tuesday, January 23.

Johnson & Johnson (NYSE:JNJ) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.